Page last updated: 2024-12-06

Brilliant Blue

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Brilliant Blue, also known as E133, is a synthetic dye commonly used in food, beverages, and pharmaceuticals. It is synthesized through a multi-step process involving the condensation of various aromatic amines and sulfonated naphthalene derivatives. The dye is known for its intense blue color and its ability to resist fading under various conditions. Brilliant Blue is primarily used as a color additive in various food products, such as sweets, candies, and ice cream. In pharmaceutical applications, it serves as a coloring agent for capsules, tablets, and other medications. Despite its widespread use, studies have investigated the potential health risks associated with Brilliant Blue consumption. Some studies suggest potential links between the dye and hyperactivity in children, while others point to possible allergic reactions. Ongoing research focuses on understanding the long-term effects of Brilliant Blue consumption, especially in vulnerable populations. The dye's potential impact on gut microbiome, its role in inflammatory responses, and its potential interactions with other substances are also being explored. The study of Brilliant Blue aims to ensure its safe and responsible use while uncovering its potential benefits and risks.'

brilliant blue: coal tar derivative food dye; used as the di-NH4 or di-Na salts; RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID19700
CHEMBL ID3184128
CHEBI ID82411
SCHEMBL ID124486

Synonyms (76)

Synonym
food blue no. 1
3844-45-9
brilliant blue
usacert blue no. 1
brilliant blue fcf
canacert brilliant blue fcf
hexacol brilliant blue a
fd&c blue 1
intracid pure blue l
food blue no.1
c.i. acid blue 9, disodium salt
fd&c blue no. 1
modr brilantni fcf [czech]
japan blue no. 1
food blue dye no. 1
aizen food blue no. 2
modr kysela 9 [czech]
benzenemethanaminium, n-ethyl-n-(4-((4-(ethyl((3-sulfophenyl)methyl)amino)phenyl)(2-sulfophenyl)methylene)-2,5-cyclohexadien-1-ylidene)-3-sulfo-, inner salt, disodium salt
brilliant blue fcf supra
merantine blue eg
einecs 223-339-8
disodium 2-{(z)-(4-{ethyl[(3-sulfonatophenyl)methyl]amino}phenyl)[(4z)-4-{ethyl[(3-sulfonatophenyl)methyl]iminio}cyclohexa-2,5-dien-1-ylidene]methyl}benzenesulfonate
benzenemethanaminium, n-ethyl-n-(4-((4-(ethyl((3-sulfophenyl)methyl)amino)phenyl)(2-sulfophenyl)methylene)-2,5-cyclohexadien-1-ylidene)-3-sulfo-, hydroxide, inner salt, disodium salt
fenazo blue xi
benzenemethanaminium, n-ethyl-n-[4-[[4-[ethyl[(3-sulfophenyl)methyl]amino]phenyl](2-sulfophenyl)methylene]-2,5-cyclohexadien-1-ylidene]-3-sulfo-, inner salt, disodium salt
ammonium, ethyl(4-(p-(ethyl(m-sulfobenzyl)amino)-alpha-(o-sulfophenyl)benzylidene)-2,5-cyclohexadien-1-ylidene)(m-sulfobenzyl)-, hydroxide, inner salt, disodium salt
fdc blue no. 1
brilliant blue fcf, disodium salt
dihydrogen (ethyl)(4-(4-(ethyl(3-sulphonatobenzyl)amino)-2'-sulphonatobenzhydrylidene)cyclohexa-2,5-dien-1-ylidene)(3-sulphonatobenzyl)ammonium, disodium salt
cosmetic blue lake
fd & c blue no. 1
ccris 97
usacert fd and c blue no. 1
modr potravinarska 2 [czech]
blue 1206
erioglaucine disodium salt
B0790
erioglaucin a
F0147
C19352
NCGC00254363-01
dtxcid40189
tox21_300516
cas-3844-45-9
dtxsid2020189 ,
blue no. 1
ppq093m8hr ,
h3r47k3tbd ,
brilliant blue e 133
hsdb 7972
modr potravinarska 2
modr brilantni fcf
modr kysela 9
unii-ppq093m8hr
benzenemethanaminium, n-ethyl-n-(4-((4-(ethyl((3-sulfophenyl)methyl)amino)phenyl)(2-sulfophenyl)methylene)-2,5-cyclohexadien-1-ylidene)-3-sulfo-, inner salt, sodium salt (1:2)
d&c blue no. 1
unii-h3r47k3tbd
n-ethyl-n-(4-((4-(ethyl((3-sulfophenyl)methyl)amino)phenyl)(2-sulfophenyl)methylene)-2,5-cyclohexadien-1-ylidene)-3-sulfobenzeneme- thanaminium hydroxide, inner salt, disodium salt
FT-0625694
disodium salt of ethyl(4-(p-(ethyl(m-sulfobenzyl)amino)-(alpha)-(o-sulfophenyl) benzylidene)-2,5-cyclohexadien-1-ylidene)(m-sulfobenzyl) ammonium hydroxide inner salt
disodium n-ethyl-n-4-((4-(ethyl((3-sulfophenyl)methyl)amino)phenyl)(2-sulfophenyl)methylene)-2,5-cyclohexadien-1-ylidene)-3-sulfobenzenemethanaminium
SCHEMBL124486
CHEBI:82411 ,
CHEMBL3184128 ,
mfcd00012141
sodium 2-((e)-(4-(ethyl(3-sulfonatobenzyl)amino)phenyl)((e)-4-(ethyl(3-sulfonatobenzyl)iminio)cyclohexa-2,5-dienylidene)methyl)benzenesulfonate
sodium 2-((4-(ethyl(3-sulfonatobenzyl)amino)phenyl)(4-(ethyl(3-sulfonatobenzyl)iminio)cyclohexa-2,5-dien-1-ylidene)methyl)benzenesulfonate
n-ethyl-n-4-4-ethyl(3-sulfophenyl)methylaminophenyl(2-sulfophenyl)methylene-2,5-cyclohexadien-1-ylidene-3-sulfo-benzenemethanaminium inner salt, disodium salt
AS-15303
Q420093
AMY22374
disodium;2-[[4-[ethyl-[(3-sulfonatophenyl)methyl]amino]phenyl]-[4-[ethyl-[(3-sulfonatophenyl)methyl]azaniumylidene]cyclohexa-2,5-dien-1-ylidene]methyl]benzenesulfonate
acid blue 9;fd&c blue no. 1;e133
D88693
AKOS037643360
bdbm50574568

Research Excerpts

Overview

Brilliant blue FCF is an alternative, nontoxic marking dye that may improve HSV conduit function and decrease intimal hyperplasia. Brilliant blue G (BBG) is a triphenylmethane dye approved for intraoperative use in ocular surgery.

ExcerptReferenceRelevance
"Brilliant blue FCF is an alternative, nontoxic marking dye that may improve HSV conduit function and decrease intimal hyperplasia."( Brilliant blue FCF as an alternative dye for saphenous vein graft marking: effect on conduit function.
Brophy, C; Cheung-Flynn, J; Hocking, KM; Komalavilas, P; Li, FD; Osgood, MJ; Voskresensky, IV; Wise, ES, 2014
)
2.57
"Brilliant blue FCF (FCF) is a nontoxic dye alternative that may also ameliorate preparation-induced injury."( Brilliant blue FCF is a nontoxic dye for saphenous vein graft marking that abrogates response to injury.
Brophy, C; Cheung-Flynn, J; Hocking, KM; Komalavilas, P; Li, FD; Luo, W, 2016
)
2.6
"Brilliant blue G (BBG) is a triphenylmethane dye approved for intraoperative use in ocular surgery, in the context of chromovitrectomy, which involves the use of vital dyes to improve the visualization of intraocular tissues during vitrectomy."( [Comprehensive strategy for retinal neuroprotection. Challenging the clinical application].
Ishibashi, T, 2012
)
1.1

Effects

Brilliant blue FCF has no toxic effects on the microbes tested and is inexpensive. Brilliant blue G has recently been introduced as one such dye with adequate ILM staining and no reported retinal toxicity.

ExcerptReferenceRelevance
"Brilliant blue FCF has no toxic effects on the microbes tested and is inexpensive."( An innovative brilliant blue FCF method for fluorescent staining of fungi and bacteria.
Chau, HW; Goh, YK; Si, BC; Vujanovic, V, 2011
)
1.45
"Brilliant blue G has recently been introduced as one such dye with adequate ILM staining and no reported retinal toxicity."( Brilliant blue G-assisted peeling of the internal limiting membrane in macular hole surgery.
Garg, S; Khanduja, S; Naithani, P; Sinha, S; Vashisht, N,
)
2.3

Toxicity

ExcerptReferenceRelevance
" No consistent, significant compound-related adverse effects were noted."( Lifetime toxicity/carcinogenicity studies of FD & C Blue No. 1 (brilliant blue FCF) in rats and mice.
Borzelleca, JF; Depukat, K; Hallagan, JB, 1990
)
0.52
" Although the use of single food additives at their regulated concentrations is believed to be relatively safe in terms of neuronal development, their combined effects remain unclear."( Synergistic interactions between commonly used food additives in a developmental neurotoxicity test.
Howard, CV; Lau, K; McLean, WG; Williams, DP, 2006
)
0.33
"The objective of the present work was to evaluate the broadest toxic effect of some synthetic additives of colorants and/or flavors on different body organs and metabolic aspects in rats."( Toxic effects of some synthetic food colorants and/or flavor additives on male rats.
El-Wahab, HM; Moram, GS, 2013
)
0.39
"The clinically used mixture of BBG/D2O seems to be safe for clinical use."( Evaluating retinal toxicity of a new heavy intraocular dye, using a model of perfused and isolated retinal cultures of bovine and human origin.
Bartz-Schmidt, KU; Doycheva, D; Januschowski, K; Mueller, S; Schramm, C; Spitzer, MS; Szurman, P, 2012
)
0.38
" ICG was toxic at all concentrations and exposure times tested."( Retinal pigmented epithelial cells cytotoxicity and apoptosis through activation of the mitochondrial intrinsic pathway: role of indocyanine green, brilliant blue and implications for chromovitrectomy.
Barros, NM; Cardoso, EB; Costa, EF; Dib, E; Farah, ME; Maia, M; Marin-Castaño, ME; Penha, FM; Pons, M; Rodrigues, EB, 2013
)
0.59
"L/Z-based dye solutions demonstrated a safe profile in in vitro and in vivo models, and may be a useful tool for staining intraocular structures."( Dye solutions based on lutein and zeaxanthin: in vitro and in vivo analysis of ocular toxicity profiles.
Badaró, E; Belfort, R; Casaroli-Marano, RP; Lima-Filho, AA; Maia, M; Martínez-Conesa, EM; Nunes, RP; Rodrigues, EB; Sousa-Martins, D, 2015
)
0.42
" Adverse events occurring in two or more cases included elevated intraocular pressure, eye pain, eye discharges, and retinal bleeding."( [Efficacy and Safety of A0001 (Brilliant Blue G250) for Internal Limiting Membrane Staining and Peeling: Phase III Investigator-initiated Multicenter Clinical Trial].
Enaida, H; Hirakata, A; Ishibashi, T; Kishimoto, J; Kubota, T; Nakanishi, Y; Nishida, K; Ogata, N; Ohji, M; Sonoda, KH; Todaka, K; Uchiyama, M, 2016
)
0.72
"A0001 was effective and safe for visualization of the ILM during vitrectomy, and there was an improvement in ease of operation."( [Efficacy and Safety of A0001 (Brilliant Blue G250) for Internal Limiting Membrane Staining and Peeling: Phase III Investigator-initiated Multicenter Clinical Trial].
Enaida, H; Hirakata, A; Ishibashi, T; Kishimoto, J; Kubota, T; Nakanishi, Y; Nishida, K; Ogata, N; Ohji, M; Sonoda, KH; Todaka, K; Uchiyama, M, 2016
)
0.72
" Phytotoxicity and soil respiration enzyme assays revealed that the decolourized dye or dye products were less toxic than the pure BB dye."( Encapsulation of Pseudomonas aeruginosa strain KBN12 decolourizes and bioremediates brilliant blue dye mediated toxicity in mung bean (Vigna radiata L.).
Amaresan, N; Chandwani, S; Gajera, A; Gamit, HA; Riddhi, M, 2023
)
1.13

Compound-Compound Interactions

A natural dye solution based on lutein and zeaxanthin alone or combined with Brilliant Blue efficiently stained the anterior capsule, vitreous, and internal limiting membrane in human cadaveric eyes. It may be a useful tool for vitreoretinal or cataract surgery.

ExcerptReferenceRelevance
"To determine whether a natural dye solution based on lutein and zeaxanthin alone or combined with Brilliant Blue stains and facilitates peeling of intraocular membranes in human eyes."( Use of lutein and zeaxanthin alone or combined with Brilliant Blue to identify intraocular structures intraoperatively.
Belfort, R; Chen, J; Farah, ME; Lima-Filho, AA; Maia, M; Moraes, M; Rodrigues, EB; Santos, LB; Sousa-Martins, D, 2012
)
0.85
"01-20%) were tested alone or combined with different Brilliant Blue concentrations (0."( Use of lutein and zeaxanthin alone or combined with Brilliant Blue to identify intraocular structures intraoperatively.
Belfort, R; Chen, J; Farah, ME; Lima-Filho, AA; Maia, M; Moraes, M; Rodrigues, EB; Santos, LB; Sousa-Martins, D, 2012
)
0.88
" Lutein and zeaxanthin alone was useful for vitreous identification and lutein and zeaxanthin combined with Brilliant Blue had strong affinity for internal limiting membrane and anterior capsule."( Use of lutein and zeaxanthin alone or combined with Brilliant Blue to identify intraocular structures intraoperatively.
Belfort, R; Chen, J; Farah, ME; Lima-Filho, AA; Maia, M; Moraes, M; Rodrigues, EB; Santos, LB; Sousa-Martins, D, 2012
)
0.84
"A natural dye solution based on lutein and zeaxanthin alone or combined with Brilliant Blue efficiently stained the anterior capsule, vitreous, and internal limiting membrane in human cadaveric eyes and may be a useful tool for vitreoretinal or cataract surgery."( Use of lutein and zeaxanthin alone or combined with Brilliant Blue to identify intraocular structures intraoperatively.
Belfort, R; Chen, J; Farah, ME; Lima-Filho, AA; Maia, M; Moraes, M; Rodrigues, EB; Santos, LB; Sousa-Martins, D, 2012
)
0.86

Bioavailability

ExcerptReferenceRelevance
" However, the great drawback it presents is a low bioavailability after oral administration."( Ion-pair approach coupled with nanoparticle formation to increase bioavailability of a low permeability charged drug.
Bermejo, M; González-Álvarez, I; González-Álvarez, M; Lozoya-Agullo, I; Merino-Sanjuán, M; Planelles, M; Sarmento, B, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
" The dye leakage response to nasal capsaicin challenge was abolished by pretreatment with topical lidocaine, general substance P analogue, topical or general high dosage capsaicin."( Study on the dye leakage response of nasal mucosa following topical, capsaicin challenge in guinea pigs.
Asakura, K; Kataura, A; Kojima, T; Narita, S; Shirasaki, H, 1992
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (27 Product(s))

Product Categories

Product CategoryProducts
Other13
Alimentos y bebidas de origen vegetal, Alimentos de origen vegetal, Cereales y patatas, Cereales y derivados, Pastas alimenticias, en:Cereal pastas, Pasta seca, Pasta de trigo duro, Macarrones de trigo duro1
Alimentos y bebidas de origen vegetal, Alimentos de origen vegetal, Condimentos, Plantas culinarias, Plantas aromáticas, Productos deshidratados, Especias, en:aromatic-herbs, Alimentos de origen vegetal deshidratados, Plantas aromáticas secas molidas, Per1
Produits de la mer, Poissons et dérivés, Poissons, Préparations de poisson, Surimi, en:preparations-made-from-fish-meat1
Snacks, Snacks sucrés, Cacao et dérivés, Chocolats, Chocolats au lait, Chocolats au riz, Chocolats au lait au riz1
Condimentos, Sales, en:groceries1
Aliments et boissons à base de végétaux, Aliments d'origine végétale, Matières grasses, Matières grasses végétales, Huiles, Huiles de fruits et graines de fruits, Huiles de pépins de raisins1
Aliments et boissons à base de végétaux, Aliments d'origine végétale, Matières grasses, Matières grasses végétales, Produits de l'olivier, Huiles, Huiles d'olive, Huiles d'olive vierges extra, Huiles d'olive vierges1
Matières grasses1
Aliments et boissons à base de végétaux, Aliments d'origine végétale, Matières grasses, Fruits à coques et dérivés, Matières grasses végétales, Huiles, Huiles de fruits à coques, Huiles de noix1
Bebidas, Aguas1
Active Lifestyle & Fitness4

Products

ProductBrandCategoryCompounds Matched from IngredientsDate Retrieved
Legendary Foods Cake Style Tasty Pastry Birthday Cake -- 2.2 oz Each / Pack of 10Legendary FoodsActive Lifestyle & Fitnesscitric acid, red no. 40, blue no. 1, cellulose, citric acid, Erythritol, glycerin, baking soda, yellow no. 5, sucralose2024-11-29 10:47:42
Legendary Foods Cake Style Tasty Pastry Chocolate Cake -- 2.2 oz Each / Pack of 10Legendary FoodsActive Lifestyle & Fitnesscitric acid, red no. 40, blue no. 1, cellulose, citric acid, Erythritol, baking soda, yellow no. 5, sucralose2024-11-29 10:47:42
Legendary Foods Protein Pastry Strawberry -- 10 PackLegendary FoodsActive Lifestyle & Fitnesscitric acid, red no. 40, blue no. 1, cellulose, citric acid, Erythritol, malic acid, baking soda, yellow no. 5, sucralose2024-11-29 10:47:42
Legendary Foods Protein Sweet Roll Wildberry -- 8 PackLegendary FoodsActive Lifestyle & Fitnesscitric acid, red no.40, blue no.1, cellulose, citric acid, Erythritol, glycerin, sucralose2024-11-29 10:47:42

Drug Classes (1)

ClassDescription
organic molecular entityAny molecular entity that contains carbon.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (23)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency20.08930.007215.758889.3584AID1224835
RAR-related orphan receptor gammaMus musculus (house mouse)Potency6.01340.006038.004119,952.5996AID1159521; AID1159523
GLI family zinc finger 3Homo sapiens (human)Potency3.88250.000714.592883.7951AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency14.03530.000221.22318,912.5098AID1259243; AID1259247; AID743042; AID743054
caspase 7, apoptosis-related cysteine proteaseHomo sapiens (human)Potency12.24170.013326.981070.7614AID1346978
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency15.03180.001022.650876.6163AID1224838; AID1224839; AID1224893
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency14.58260.003041.611522,387.1992AID1159552; AID1159553; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency14.22450.000817.505159.3239AID1159527; AID1159531
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency12.87440.001530.607315,848.9004AID1224841; AID1224842; AID1224848; AID1224849; AID1259401; AID1259403
pregnane X nuclear receptorHomo sapiens (human)Potency13.73540.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency12.55670.000229.305416,493.5996AID1259244; AID1259248; AID743079; AID743080; AID743091
caspase-3Homo sapiens (human)Potency12.24170.013326.981070.7614AID1346978
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency17.29180.001723.839378.1014AID743083
thyroid stimulating hormone receptorHomo sapiens (human)Potency9.55690.001628.015177.1139AID1224843; AID1224895; AID1259385; AID1259393; AID1259395
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency29.33220.057821.109761.2679AID1159526; AID1159528
Histone H2A.xCricetulus griseus (Chinese hamster)Potency14.96110.039147.5451146.8240AID1224845; AID1224896
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency15.12120.000323.4451159.6830AID743065; AID743067
histone deacetylase 9 isoform 3Homo sapiens (human)Potency5.69880.037617.082361.1927AID1259364; AID1259388
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency12.24170.001557.789015,848.9004AID1259244
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency12.24170.001551.739315,848.9004AID1259244
ATPase family AAA domain-containing protein 5Homo sapiens (human)Potency19.40170.011917.942071.5630AID651632
Ataxin-2Homo sapiens (human)Potency19.40170.011912.222168.7989AID651632
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Pannexin-1Mus musculus (house mouse)IC50 (µMol)0.27000.27005.135010.0000AID1772526
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (18)

Processvia Protein(s)Taxonomy
cell population proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of B cell proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
nuclear DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
signal transduction in response to DNA damageATPase family AAA domain-containing protein 5Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
isotype switchingATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of isotype switching to IgG isotypesATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloadingATPase family AAA domain-containing protein 5Homo sapiens (human)
regulation of mitotic cell cycle phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of cell cycle G2/M phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of receptor internalizationAtaxin-2Homo sapiens (human)
regulation of translationAtaxin-2Homo sapiens (human)
RNA metabolic processAtaxin-2Homo sapiens (human)
P-body assemblyAtaxin-2Homo sapiens (human)
stress granule assemblyAtaxin-2Homo sapiens (human)
RNA transportAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (8)

Processvia Protein(s)Taxonomy
protein bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP hydrolysis activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloader activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
RNA bindingAtaxin-2Homo sapiens (human)
epidermal growth factor receptor bindingAtaxin-2Homo sapiens (human)
protein bindingAtaxin-2Homo sapiens (human)
mRNA bindingAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (11)

Processvia Protein(s)Taxonomy
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
Elg1 RFC-like complexATPase family AAA domain-containing protein 5Homo sapiens (human)
nucleusATPase family AAA domain-containing protein 5Homo sapiens (human)
cytoplasmAtaxin-2Homo sapiens (human)
Golgi apparatusAtaxin-2Homo sapiens (human)
trans-Golgi networkAtaxin-2Homo sapiens (human)
cytosolAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
membraneAtaxin-2Homo sapiens (human)
perinuclear region of cytoplasmAtaxin-2Homo sapiens (human)
ribonucleoprotein complexAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1772526Inhibition of mouse Panx-1 expressed in Xenopus laevis oocytes assessed as inhibition of membrane current cells held at -60 mV and voltage steps to +60 mV in presence of CBX measured by Whole cell voltage clamp assay relative to control2021European journal of medicinal chemistry, Nov-05, Volume: 223Design and synthesis of the first indole-based blockers of Panx-1 channel.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (222)

TimeframeStudies, This Drug (%)All Drugs %
pre-199023 (10.36)18.7374
1990's15 (6.76)18.2507
2000's67 (30.18)29.6817
2010's95 (42.79)24.3611
2020's22 (9.91)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 76.06

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index76.06 (24.57)
Research Supply Index5.52 (2.92)
Research Growth Index5.00 (4.65)
Search Engine Demand Index133.77 (26.88)
Search Engine Supply Index2.03 (0.95)

This Compound (76.06)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials12 (5.06%)5.53%
Reviews6 (2.53%)6.00%
Case Studies7 (2.95%)4.05%
Observational0 (0.00%)0.25%
Other212 (89.45%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]